Literature DB >> 8156857

Terson's syndrome in a patient with acute promyelocytic leukemia on all-trans retinoic acid treatment.

A M Abu el-Asrar1, A K al-Momen, M S Harakati.   

Abstract

The syndrome of vitreous hemorrhage in association with any form of intracranial bleeding is known as Terson's syndrome. Acute promyelocytic leukemia (APL) constitutes 5% to 15% of cases of acute nonlymphocytic leukemias, in which hemorrhagic diathesis often occurs and results in a rapid fatal outcome. In this report we describe a patient with APL who developed cerebral bleeding in association with bilateral subhyaloid and vitreous hemorrhages consistent with Terson's syndrome while she was on all-trans retinoic acid induction therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8156857     DOI: 10.1007/bf01215451

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  11 in total

1.  Acute promyelocytic leukaemia: haemorrhagic manifestation and morphologic criteria.

Authors:  H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1975-03       Impact factor: 6.998

2.  Long-term visual outcome in Terson syndrome.

Authors:  P N Schultz; W M Sobol; T A Weingeist
Journal:  Ophthalmology       Date:  1991-12       Impact factor: 12.079

3.  Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia.

Authors:  H R Gralnick; E Abrell
Journal:  Br J Haematol       Date:  1973-01       Impact factor: 6.998

4.  Relationship between blast-cell morphology and occurrence of a syndrome of disseminated intravascular coagulation.

Authors:  C Sultan; M Heilmann-Gouault; M Tulliez
Journal:  Br J Haematol       Date:  1973-02       Impact factor: 6.998

5.  Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction.

Authors:  A J Collins; C D Bloomfield; B A Peterson; R W McKenna; J R Edson
Journal:  Arch Intern Med       Date:  1978-11

6.  The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias.

Authors:  C Chomienne; P Ballerini; N Balitrand; M E Huang; I Krawice; S Castaigne; P Fenaux; P Tiollais; A Dejean; L Degos
Journal:  Leukemia       Date:  1990-12       Impact factor: 11.528

7.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

Authors:  M E Huang; Y C Ye; S R Chen; J R Chai; J X Lu; L Zhoa; L J Gu; Z Y Wang
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

8.  Acute promyelocytic leukemia in 57 previously untreated patients.

Authors:  C Cordonnier; J P Vernant; B Brun; M G Heilmann; M Kuentz; P Bierling; J P Farcet; M Rodet; N Duedari; M Imbert
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

9.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

10.  Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17.

Authors:  J Borrow; A D Goddard; D Sheer; E Solomon
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

View more
  2 in total

Review 1.  Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.

Authors:  J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

2.  A Case of Acute Promyelocytic Leukemia With Retinal Hemorrhages Beneath Internal Limiting Membrane During Clinical Remission.

Authors:  Marwan M Balubaid; Abdullah S Alqahtani
Journal:  Cureus       Date:  2021-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.